Kinnate BioPharma Inc.
KNTE
|
|
| |
|
| Trading Volume | 2,812,224 |
|
|
2.66 - 1.07 |
| Market Cap Full | $ 124.8M |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | - | - | 12.2% | 2.5% |
| Q2 | - | - | -0.4% | -51.5% |
| Q3 | - | - | - | -53.8% |
| Q4 | - | - | - | 68.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | 4.2 | 7.7 | -0.4 | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 23.4 | -29.9 | 18.4 | -59.5 | 70 | -29.5 | -1.3 | -25.4 | -37.2 | -20.7 | 104.5 | 4.4 |
| 2022 | |||||||||||
| -38 | -29.1 | 44.7 | -33.7 | 7 | 57.8 | -13.8 | 33.2 | -17.5 | -29.5 | -6.1 | -23 |
| 2021 | |||||||||||
| -17.6 | 5.3 | -13.8 | -9.9 | -12.5 | -0.9 | -5.5 | 0.5 | 4.1 | 3.3 | -15.9 | -11.3 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.7 | -0.6 | -0.4 |
| Q2 | -0.7 | -0.6 | -0.5 |
| Q3 | -0.7 | -0.7 | -0.6 |
| Q4 | 0 | -0.7 | -0.6 |
| A | -2.06 | -2.6 | -2.1 |